INTERPRETING CLINICAL DATA: Highlights From ASCO 2016

Transcription

1 INTERPRETING CLINICAL DATA: Highlights From ASCO 2016 SATURDAY, JUNE 25, 2016 Detroit Marriott - Troy, MI

2 AGENDA Time Topic Speaker 7:30 am Registration and Continental Breakfast 8:00 am Opening Remarks/Welcome Samuel M. Silver, MD, PhD, MACP, FASCO 8:10 am Sarcoma Scott Schuetze, MD, PhD 8:40 am Neuro-Oncology Tobias Walbert MD, PhD, MPH 9:10 am Head and Neck Cancer Francis Worden, MD 9:40 am BREAK 10:10 am Palliative Care Susan Urba, MD 10:40 am Leukemia/Lymphoma/, MD Myeloma/MPN 11:10 am Breast Cancer Norah Lynn Henry, MD, PhD 11:40 am LUNCH 12:00 pm Hazardous Drug Handling Christopher Friese, RN, PhD, AOCN Policy Updates: Implications for Oncology Practices 12:30 pm Melanoma Lawrence Flaherty, MD 1:00 pm Genitourinary Cancers Phillip Palmbos, MD, PhD 1:30 pm Gastrointestinal Cancers Philip A. Philip, MD, PhD, FRCP 2:00 pm Lung Cancer Bryan Schneider, MD 2:30 pm Course Adjourns

3 FACULTY AND COURSE PLANNING COMMITTEE Faculty Craig Cole, MD Clinical Assistant Professor Lawrence Flaherty, MD Professor of Oncology Wayne State University School of Medicine Medical Director, Clinical Trials Office Barbara Ann Karmanos Cancer Institute Norah Lynn Henry, MD, PhD Associate Professor Phillip Palmbos, MD, PhD Clinical Lecturer Hematology/Oncology Philip A. Philip, MD, PhD, FRCP Professor of Oncology Wayne State University School of Medicine Director of GI & Neuroendocrine Oncology Barbara Ann Karmanos Cancer Institute Bryan Schneider, MD Associate Professor Associate Medical Director Adult Infusion/Ambulatory Treatment Center Scott Schuetze, MD, PhD Clinical Associate Professor Medical Oncology Susan G. Urba, MD Professor of Internal Medicine Medical Director Symptom Management & Supportive Care Program Tobias Walbert, MD, PhD, MPH Medical Co-Director Hermelin Brain Tumor Center Neuro-Oncology Fellowship Director Henry Ford Health System Francis Worden, MD Associate Professor of Medicine Director, Fellowship Program Hematology/Oncology Course Planning Committee Samuel M. Silver, MD, PhD, MACP, FASCO Course Director Assistant Dean for Research Professor, Division of Hematology/Oncology Department of Internal Medicine Richard Champlin, MD CME Program Chair Professor of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center Mary Kay Makarewicz Director of Programs & Operations Michigan Society of Hematology & Oncology

4 INTERPRETING CLINICAL DATA: Highlights From ASCO 2016 REGISTRATION DEADLINE: Friday, June 17, 2016 Pre-registration is encouraged since space is limited. Registration must be received by June 17 to be guaranteed a syllabus. REGISTRATION OPTIONS: ONLINE: Credit Cards accepted MAIL: MSHO Foundation 5435 Corporate Dr., Ste. 250 Troy, MI FAX: Please return completed registration form and check made payable to MSHO Foundation. Payment must be received by June 17, WALK INS: Check, Cash or Credit Card PERSONAL INFORMATION (PLEASE PRINT) Name Institution/Clinic/Practice Address Register by June 17, 2016 City State Zip Register after June 17, 2016 Physicians $ $ Retired Physicians, PAs, NPs, Nurses, $50.00 $75.00 Allied Healthcare Professionals Fellows and Residents No Fee $25.00 No refunds will be granted after June 17. For further information contact MSHO at or mmakarewicz@msho.org Phone FAX I am a: Physician NP/PA Pharmacist Are you staying for lunch? Yes No Nurse Fellow Other DEADLINE TO REGISTER: JUNE 17, 2016

5 Detroit Marriott 200 W Big Beaver Rd Troy MI MSHO has reserved a block of rooms at Detroit Marriott - Troy. Reservations can be made by calling the Marriott at Mention that you are with the MSHO meeting to receive the discounted rate. Reservation deadline is June 3. TARGET AUDIENCE This program is directed toward hematologists, medical oncologists, surgical oncologists, radiation oncologists, hematology/oncology fellows, pharmacists, oncology nurses and others delivering care to cancer patients. ACCREDITATION/CREDIT DESIGNATION This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Texas MD Anderson Cancer Center and the Michigan Society of Hematology and Oncology. The University of Texas MD Anderson Cancer Center is accredited by the ACCME to provide continuing medical education for physicians. The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. EDUCATIONAL OBJECTIVES After participating in the activity, the participant should be able to: Apply advances and scientific and translational research in the care of their patients (knowledge, competence, performance). List and assimilate the difficulties in interpreting data presented at scientific meetings (knowledge, competence). Enhance physicians ability to analyze speakers conclusions at medical meetings (knowledge, competence). Implement new practices or review existing ones to improve the quality of care delivered based on knowledge gained at this symposium (knowledge, competence, performance, patient outcomes). STATEMENT OF NEED Oncology is a continuously evolving area of medicine and new developments provide tools for the physicians, scientists and health care professionals to help diagnose and treat cancer. Continuing education is essential to study and evaluate new findings, to inform practitioners of new clinical applications and to improve patient care.